You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PLAN B Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Plan B patents expire, and what generic alternatives are available?

Plan B is a drug marketed by Fdn Consumer and is included in two NDAs.

The generic ingredient in PLAN B is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Plan B

A generic version of PLAN B was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PLAN B?
  • What are the global sales for PLAN B?
  • What is Average Wholesale Price for PLAN B?
Summary for PLAN B
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 104
Patent Applications: 3,678
What excipients (inactive ingredients) are in PLAN B?PLAN B excipients list
DailyMed Link:PLAN B at DailyMed
Drug patent expirations by year for PLAN B
Drug Sales Revenue Trends for PLAN B

See drug sales revenues for PLAN B

US Patents and Regulatory Information for PLAN B

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fdn Consumer PLAN B levonorgestrel TABLET;ORAL 021045-001 Jul 28, 1999 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fdn Consumer PLAN B levonorgestrel TABLET;ORAL 021045-002 Aug 24, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fdn Consumer PLAN B ONE-STEP levonorgestrel TABLET;ORAL 021998-001 Jul 10, 2009 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.